14-3-3 eta antibodies and uses thereof for the diagnosis and...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/18 (2006.01) A61K 39/395 (2006.01) A61P 19/02 (2006.01) C07K 16/00 (2006.01) G01N 33/53 (2006.01) G01N 33/543 (2006.01)

Patent

CA 2706476

The invention provides anti-14-3-3 eta antibodies that specifically bind to the human 14-3-3 eta protein isoform in its natural configuration while exhibiting selectivity over human 14-3-3 alpha, beta, delta, epsilon, gamma, tau, and zeta protein isoforms. Methods, kits and pharmaceutical compositions comprising said specific anti-14-3-3 eta antibodies are further provided for the diagnosis and treatment of arthritis.

La présente invention concerne des anticorps anti-14-3-3 êta qui se lient spécifiquement à l'isoforme de la protéine 14-3-3 êta humaine dans sa configuration naturelle tout en présentant une sélectivité vis-à-vis des isoformes protéiques 14-3-3 alpha, bêta, delta, epsilon, gamma, tau, et zeta humaines. L'invention concerne en outre des procédés, des trousses et des compositions pharmaceutiques contenant lesdits anticorps anti-14-3-3 êta spécifiques pour le diagnostic et le traitement de l'arthrite.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

14-3-3 eta antibodies and uses thereof for the diagnosis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 14-3-3 eta antibodies and uses thereof for the diagnosis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 14-3-3 eta antibodies and uses thereof for the diagnosis and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1850070

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.